[Corrections] Correction to Lancet Oncol 2012; 13: 1261, 1263
Denham JW, Wilcox C, Joseph D, et al. Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial. Lancet Oncol 2012; 13: 1260–70—In this Article, the PSA strata for randomisation should read “(<10 μg/L, 10–20 μg/L, and >20 μg/L)”. Data for initial PSA groupings and radiation dose in were incorrect; the corrected table is shown below. These corrections have been made to the online version as of Sept 1 2014.
Source: The Lancet Oncology - Category: Cancer & Oncology Authors: The Lancet Oncology Tags: Corrections Source Type: research